Topic: treatment-resistant breast cancer
A drug that causes cancer cells to divide too rapidly and die was effective when combined with chemo in mouse models of triple-negative breast cancer.
A Boston Children's team has developed a method for knocking out the oncogene Lipocalin 2 using CRISPR carried by soft nanoparticles.
A modified form of poliovirus seems to shrink breast tumors by latching onto a protein that's heavily expressed on the surface of some cancer cells.
The past week brought discoveries related to tumor metastasis, the virulence of a superbug, and breast cancer risk.